par Awada, Ahmad
;Piccart-Gebhart, Martine
;Jones, Suzanne F;Peck, Ronald A;Gil, Thierry
;Lebwohl, David;Wu, Chi-Yuan;Burris, Howard A
Référence Cancer chemotherapy and pharmacology, 63, 3, page (417-425)
Publication Publié, 2009-02



Référence Cancer chemotherapy and pharmacology, 63, 3, page (417-425)
Publication Publié, 2009-02
Article révisé par les pairs
Titre: |
|
Auteur: | Awada, Ahmad; Piccart-Gebhart, Martine; Jones, Suzanne F; Peck, Ronald A; Gil, Thierry; Lebwohl, David; Wu, Chi-Yuan; Burris, Howard A |
Informations sur la publication: | Cancer chemotherapy and pharmacology, 63, 3, page (417-425) |
Statut de publication: | Publié, 2009-02 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Dose-finding |
Ixabepilone | |
Solid tumors | |
Weekly schedule | |
MeSH keywords: | Aged |
Antineoplastic Agents -- administration & dosage | |
Antineoplastic Agents -- adverse effects | |
Antineoplastic Agents -- therapeutic use | |
Cohort Studies | |
Epothilones -- administration & dosage | |
Epothilones -- adverse effects | |
Epothilones -- pharmacokinetics | |
Epothilones -- therapeutic use | |
Female | |
Humans | |
Male | |
Maximum Tolerated Dose | |
Middle Aged | |
Neoplasms -- drug therapy | |
Note générale: | Clinical Trial, Phase I |
Journal Article | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0344-5704 |
info:doi/10.1007/s00280-008-0751-5 | |
info:scp/58249142470 | |
info:pmid/18446338 |